Literature DB >> 8021972

In vitro modulation of changes in ganglioside patterns of differentiating neurons in the presence of an anti-GM1 antibody.

M L Allende1, P Panzetta.   

Abstract

Retinal cells from 7-day-old chicken embryos were cultured in the presence of a polyclonal anti-GM1 antibody, at low and high density in a "sandwich cell culture". Cells that were about 80% neurofilament positive at all times, changed their morphology and emitted processes as controls. By examining immunocytochemical expression of gangliosides, cells cultured in the presence of the antibody maintained GD3 expression longer than controls, albeit the expression of the gangliotetraosylgangliosides (GTOG) was not considerably affected. This leads to an extension of the transient period in which differentiating cells coexpressed both types of gangliosides (GD3 and GTOG). At 3-4 days in vitro the relative synthesis of GD3 was about 30% higher and that of GD1a about 40% lower than in controls, indicating a delay in the shift of the synthesis pattern. Nevertheless, the pattern of ganglioside composition resembled at 4 days in vitro. Results indicate that the anti-GM1 antibody may modulate the expression and synthesis of gangliosides without a detectable decrease in neuritogenesis. Considering that the emission of neurites occurs in coexpressing GD3 and GTOG neurons, it is suggested that neuritogenesis could be irrespective of losing the GD3 expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021972     DOI: 10.1002/jnr.490370409

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  2 in total

Review 1.  The role of globo-series glycolipids in neuronal cell differentiation--a review.

Authors:  T Ariga; R K Yu
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 2.  Ganglioside expression during differentiation of chick retinal cells in vitro.

Authors:  P Panzetta; M L Allende
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.